• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AJMC® in the Press, July 21, 2017

Article

Coverage of our peer-reviewed research in the healthcare and mainstream press.

In a column for Massachusetts news outlet Melrose Free Press, State Senator Jason Lewis outlined the promises of telemedicine and his goal to pass legislation that would expand access to telehealth services. He cited a 2015 study published in The American Journal of Managed Care® (AJMC®), “Opportunity Costs of Ambulatory Medical Care in the United States,” which found that although medical visits take up an average 2 hours of a patient’s time, only 20 minutes are actually spent face-to-face with a physician. Lewis argued that telemedicine visits can eliminate the time spent traveling to clinics and ideally provide more convenient and accessible care.

A press release from insurer Anthem described its survey published in Benefits Quarterly, which found that 90% of large employers considered the cost of new specialty drugs a challenge. To explain this burden, it referenced a Payer Perspective article titled “The Growing Cost of Specialty Pharmacy: Is it Sustainable?” and published by AJMC® in 2013. This article discussed how the array of specialty drugs on the market had “grown substantially” from 10 in 1990 to nearly 300 in 2012.

There are 3 significant challenges providers face in implementing payments, according to an article on RevCycleIntelligence.com, including the unexpected spending that can arise as a result of complications or nonadherence. It illustrated this point with a quote from a 2016 AJMC® interview, “Dr Joshua Cohen Considers the Cons of Bundled Payments.” “There are situations where using a bundle may be inappropriate because the factors that are influencing differences in cost among patients are things that the provider doesn’t actually control,” Cohen said.

Related Videos
Beau Raymond, MD
Judith Alberto, MHA, RPh, BCOP, director of clinical initiatives, Community Oncology Alliance
Yuqian Liu, PharmD
Jenny Craven, PharmaD, BCPS
Kimberly Westrich, MA
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Sarah Bajorek, PhD, BCACP, MBA.
Pat Van Burkleo
Video 11 - "Social Burden and Goals of Therapy for Patients with Bronchiectasis"
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.